Guanfacine in Comorbid ADHD & Tourettes Syndrome

Creators: Millichap, J. Gordon

Abstract

An open-label study of guanfacine (1.5 mg/d), an a-adrenergic agonist, in 10 children with TS + ADHD, aged 8 to 16 years, was reported from the Yale University School of Medicine, New Haven, CT, and Johns Hopkins Medical Institutions, Baltimore, MD.

Files

PNB-9-66-b.pdf

Files (2.3 MB)

Name	Size	Download all
PNB-9-66-b.pdf md5:fb831e242588d1dbce7704149e4f1f90	2.3 MB	Preview Download

Additional details